SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT ON FORM 8-K
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: April 15, 1997
(Date of Earliest event reported)
*******************************
MEDIZONE CANADA LIMITED
-----------------------
(Exact name of Registrant as specified in its charter)
Utah 33-16757-D 87-0431771
---- ---------- ----------
State of Commission IRS Taxpayer
Incorporation Registration No. I.D. Number
123 East 54th Street, Suite 7B, New York, New York 10022
--------------------------------------------------------
Address of Principal executive offices
Registrant's telephone number: (212) 421-0303
<PAGE>
Item 5. Other Events.
Medizone Canada Limited (the "Registrant") did not file its Annual Report
on Form 10-K for the period ended December 31, 1996 on April 15, 1996, as
required pursuant to Rule 12b-25 promulgated under the Securities and Exchange
Act of 1934. On March 31, 1996, the Registrant had filed the textual portion of
its Form 10-K, which omitted the financial statements and other financial
information required to be included in that report, together with a Form 12b-25
which stated, as the reason for the incomplete filing, that the Registrant was
without the financial resources to retain its accountant so as to complete the
Registrant's annual audit in a timely manner. As of the date of this current
report, the Registrant continues to be without the financial resources to retain
its accountants. While the Registrant continues to seek these funds, it cannot
state with certainty when or if it will acquire the funds required to retain its
accountants.
2
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Act of 1934, the Registrant
has duly caused this Current Report to be signed on its behalf by the
undersigned, one of its officers thereunto duly authorized.
Dated: New York, NY
April 16, 1997
MEDIZONE CANADA LIMITED
By: s/Joseph S. Latino
Joseph S. Latino
President
3
